Abstract Schiff bases are aldehyde-or ketone-like compounds in which the carbonyl group is replaced by an imine or azomethine group. They are widely used for industrial purposes and also exhibit a broad range of biological activities. This short review compiles examples of the most promising antimalarial, antibacterial, antifungal, and antiviral Schiff bases. An overview of synthetic methodologies used for the preparation of Schiff bases is also described.
Introduction
Schiff bases, named after Hugo Schiff [1] , are formed when any primary amine reacts with an aldehyde or a ketone under specific conditions. Structurally, a Schiff base (also known as imine or azomethine) ( Fig. 1 ) is a nitrogen analogue of an aldehyde or ketone in which the carbonyl group (C‚O) has been replaced by an imine or azomethine group.
Schiff bases are some of the most widely used organic compounds. They are used as pigments and dyes, catalysts, intermediates in organic synthesis, and as polymer stabilisers [2] . Schiff bases have also been shown to exhibit a broad range of biological activities, including antifungal, antibacterial, antimalarial, antiproliferative, anti-inflammatory, antiviral, and antipyretic properties [2, 3] . Imine or azomethine groups are present in various natural, natural-derived, and non-natural compounds (see Fig. 2 for some examples). The imine group present in such compounds has been shown to be critical to their biological activities [4] [5] [6] .
In this review we present the general approaches to the synthesis of Schiff bases. We also highlight the most significant examples of compounds belonging to this class, which exhibit antimalarial, antibacterial, antifungal, and/or antiviral activities to have been reported in the literature. The relationship between Schiff bases and other pharmacological activities, such as antiproliferative activities, are not included in this review.
Synthesis of Schiff bases
The first preparation of imines was reported in the 19th century by Schiff (1864) . Since then a variety of methods for the synthesis of imines have been described [7] . The classical synthesis reported by Schiff involves the condensation of a carbonyl compound with an amine under azeotropic distillation [8] . Molecular sieves are then used to completely remove water formed in the system [9] . In the 1990s an in situ method for water elimination was developed, using dehydrating solvents such as tetramethyl orthosilicate or trimethyl orthoformate [10, 11] . In 2004, Chakraborti et al. [12] demonstrated that the efficiency of these methods is dependent on the use of highly electrophilic carbonyl compounds and strongly nucleophilic amines. They proposed as an alternative the use of substances that function as Bro¨nsted-Lowry or Lewis acids to activate the carbonyl group of aldehydes, catalyze the nucleophilic attack by amines, and dehydrate the system, eliminating water as the final step [12] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] .
In the past 12 years a number of innovations and new techniques have been reported, including solvent-free/clay/microwave irradiation, solid-state synthesis, K-10/microwave, water suspension medium, [bmim]BF 4 /molecular sieves, infrared irradiation/no solvent, NaHSO 4 AESiO 2 /microwave/solventfree, solvent-free/CaO/microwave, and silica/ultrasound irradiation [25] [26] [27] [28] [29] [30] [31] [32] [33] . Among these innovations, microwave irradiation has been extensively used due to its operational simplicity, enhanced reaction rates, and great selectivity [32] . The use of microwave irradiation commenced with the independent studies of Rousell and Majetich groups [34, 35] . Microwave irradiation is less environmentally problematic than other methods because it abolishes the excessive use of aromatic solvents and the Dean-Stark apparatus for azeotropic removal of water. Another feature of this technique is that the reactions achieve high efficiency in a shorter period of time.
Biological activities of schiff bases

Antimalarial activity
Malaria is a neglected disease that still causes serious public health problems. Every year, approximately 500 million people are afflicted by the disease, of whom around 1-3 million die, 90% of who in sub-Sahara Africa are primarily children [36] . Malaria is currently found in more than 100 countries throughout Africa, Latin America, Asia, and Oceania. Human malaria is mainly caused by four species of Plasmodium (P. falciparum, P. vivax, P. ovale, and P. malariae). The female mosquito of the Anopheles genus is the vector of Plasmodium [37] .
The search for new drugs, vaccines, and insecticides to prevent or treat this disease is clearly a priority.
Schiff bases have been shown to be interesting moieties for the design of antimalarial agents. Ancistrocladidine (1; Fig. 2 ) is a secondary metabolite produced by plants from the families Ancistrocladaceae and Dioncophyllaceae that present an imine group in its molecular scaffold. Compound 1 has been shown to be active against P. falciparum K1 and 3D7. The minimum inhibitory concentrations (MIC values) of ancistrocladidine necessary to completely abolish P. falciparum K1 and 3D7 growth were 0.3 and 1.9 lg/mL, respectively. Interestingly, compound 1 was 90-and 10-fold more selective to P. falciparum K1 and 3D7,respectively than to rat skeletal myoblast L-6 cells [4] . Rathelot et al. [38] described the synthesis of Schiff base-functionalised 5-nitroisoquinolines and investigated the in vitro activity of these compounds against an ACC Niger chloroquine resistant P. falciparum strain. Schiff base 5 (Fig. 3) was the most effective antimalarial agent among the synthesised 5-nitroisoquinoline derivatives. The concentration of compound 5 necessary to inhibit P. falciparum growth by 50% (IC 50 ) was 0.7 lg/mL. Under the same experimental conditions the IC 50 value for chloroquine was 0.1 lg/mL [38] .
Antibacterial activity
The increase in the mortality rate associated with infectious diseases is directly related to bacteria that exhibit multiple resistance to antibiotics. The lack of effective treatments is the main cause of this problem [39, 40] . The development of new antibacterial agents with novel and more efficient mechanisms of action is definitely an urgent medical need [41] .
Schiff bases have been pointed to as promising antibacterial agents. For example, N-(salicylidene)-2-hydroxyaniline (4; Fig. 2 ) is effective against Mycobacterium tuberculosis H37Rv, exhibiting an MIC value of 8 lg/mL [5] . The selectivity of compound 4 was checked by performing experiments with J774 macrophages. No cytotoxic effect on J774 macrophages was observed for compound 4, even when it was tested at concentrations as high as 1000 lg/mL. More than 80% of macrophage cells were viable at such experimental conditions, demonstrating the high selectivity of compound 4.
The synthesis and antimicrobial activity of a series of Schiff bases derived from the condensation of 5-chloro-salicylaldehyde and primary amines has recently been reported [42] . The 5-chloro-salicylaldehyde-Shiff base derivatives 6-15 ( Fig. 3) were most active against at least one of the evaluated bacterial species. Pseudomonas fluorescence was the strain most sensitive to compounds 6-11 and 13-15, with MIC values ranging from 2.5 to 5.2 lg/mL. The MIC value for the reference drug kanamycin against the same bacterial strain was 3.9 lg/mL. The Schiff bases 6, 7, 9-11, 14, and 15 presented MIC values in the range of 1.6-5.7 lg/mL against Escherichia coli, while the MIC value for kanamycin was 3.9 lg/mL. Bacillus subtilis was sensitive to the Schiff base 14 only (MIC = 1.8 lg/mL). The MIC values for compounds 6 and 7 against Staphylococcus aureus were, respectively, 3.1 and 1.6 lg/mL [42] .
Isatin-derived Schiff bases have also been reported to possess antibacterial activity [43] . Twenty-eight bacteria of clinical interest were used in the studies performed by Pandeya and colleagues. The authors disclosed the isatin-derived Schiff base 16 (Fig. 3) as the most potent compound amongst those syn- thesised against all the pathogenic bacteria studied. The MIC values for compound 16 against E. coli NCTC 10418, Vibrio cholerae non-01, Enterococcus faecalis, Proteus shigelloides were 2.4, 0.3, 1.2, and 4.9 lg/mL, respectively, while the MIC values for sulfamethoxazole (reference drug) against the same bacterial strains were in the range of 312-5000 lg/mL. Thus compound 16 was notably 1040-, 1040-, 4160-, and 1020-fold more potent than sulphamethoxazole. Other isatinderived Schiff bases have been described in the literature, but with no expressive antibacterial activities [44, 45] . The isoniazid-derived Schiff base 17 ( Fig. 3) was active against M. tuberculosis H37Rv, exhibiting an MIC value of 0.03 mg/L [46] . In this respect, compound 17 was slightly more potent than isoniazid, its immediate synthetic precursor. Additionally, the isoniazid-derived Schiff base 17 was not toxic against the cell line VERO (epithelial cells from healthy monkey kidney). The IC 50 for compound 17 against VERO cells was as high as 1 g/mL, indicating that this isoniazid-derived Schiff base is selective for bacterial cells. The therapeutic safety and effectiveness for compound 17 is higher than 40,000, making this Schiff base an excellent lead for the development of antitubercular agents [46] .
In 2005, Panneerselvam et al. [21] described the synthesis and in vitro antibacterial activity of eleven morpholine-derived Schiff bases. Fig. 3 shows the chemical structure of three of them (compounds [18] [19] [20] . The authors found that S. aureus and Micrococcus luteus were the bacteria most sensitive to the morpholine-derived Schiff base 18 (MIC = 20 and 32 lg/ mL, respectively). Streptococcus epidermidis was more sensitive to the morpholine-derived Schiff base 19 (MIC = 17 lg/mL) and Bacillus cereus and E. coli were more sensitive to compound 20 (MIC = 21 and 16 lg/mL, respectively).
Schiff bases with a 2,4-dichloro-5-fluorophenyl moiety are also effective in the inhibition of bacterial growth. Schiff bases from this class (compounds 21-24 in Fig. 3 ) completely inhibited the growth of S. aureus, E. coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae [47] . MIC values for these compounds varied from 6.3 to 12.5 lg/mL, which are comparable to those obtained for the reference drug ciprofloxacin [47] .
Madurahydroxylactone Schiff bases are imines derived from natural products. Madurahydroxylactones are secondary metabolites produced by the plant Actinomadura rubra [48] . The imines 25-30 (Fig. 4) are examples of Schiff bases belonging to this class. With the exception of compounds 25 and 30, all madurahydroxylactone-derived compounds were effective in the in vitro inhibition of B. subtilis, Micrococcus flavus, Sarcina lutea, and S. aureus growth, with MIC values varying from 0.2 to 3.1 lg/mL [49] . These same compounds (26) (27) (28) (29) presented very low activity against Mycobacterium phlei or Proteus vulgaris (MIC values higher than >50.0 lg/mL) [49] .
Other molecules of natural or non-natural origin that are platforms for the synthesis of Schiff bases for antibacterial activities include amino acids, coumarins, sulfonamides, or resacetophenones, aminothiazolyl bromocoumarins, crown ethers, O-phthaldehyde, or 2-aminophenol and 1,2,4-triazoles [24, [50] [51] [52] [53] [54] [55] [56] . The antibacterial property of compounds representative of these classes was examined. However, they did not exhibit any notable activity.
Antifungal activity
Fungal infections are not usually limited to the superficial tissues; indeed, a significant increase in life threatening systemic fungal infections has been reported [57] . The fundamental reason for this is the increasing number of patients at risk, including those with advanced age, major surgery, immunosuppressive therapy, acquired immunodeficiency syndrome (AIDS), cancer treatment, and solid-organ and hematopoietic stem cell transplantation [58] . The search and development of more effective antifungal agents are mandatory [59, 60] and some Schiff bases are known to be promising antifungal agents.
Alternaria brassicae and Alternaria brassicicola are phytopathogenic fungi that severely affect the production of most cruciferous crops (broccoli, cauliflower, mustard, turnip, cabbage, rape, and radish). N-(Salicylidene)-2-hydroxyaniline 4 (Fig. 2) at the concentration of 500 ppm inhibited the growth of these fungi by 67-68% [61] . Compounds 2 and 3 ( Fig. 2) are examples of chitosan-derived Schiff bases with antifungal activity. They inhibited the growth of Botrytis cinerea and Colletotrichum lagenarium by 26-33% and 35-38% when used at 1000 ppm, respectively [6] . Overall, studies evaluating the effect of Schiff bases on phytopathogenic fungal growth have been modest and deserve more investigation.
Schiff bases with a 2,4-dichloro-5-fluorophenyl moiety, such as compounds 21 (Fig. 3) and 31-34 (Fig. 5) [62] . The isatin-derived Schiff bases 16 (Fig. 3) and 41-51 (Fig. 5) were considerably active against Microsporum audouinii (MIC values ranging from 2.4 to 9.7 lg/mL) and Microsporum gypseum (MIC values ranging from 1.2 to 9.7 lg/mL) [43] . Compounds 16 and 41-51 also inhibited the growth of Candida albicans, Aspergillus niger, Cryptococcus neoformans, T. mentagrophytes, E. floccosum, and Histoplasma capsulatum at MIC values higher than 10 lg/mL and lower than 79 lg/mL [43] . In another study, Panneerselvam et al. [21] showed that the growth of both C. albicans and A. niger was compromised by treatment with compound 20 (Fig. 3) at 20 lg/mL or compound 52 (Fig. 5) at 30 lg/mL.
As for antibacterial activity, natural product-derived Schiff bases are also promising for the design of new antifungal agents. Domb and colleagues have described an interesting approach to synthesize a nystatin-dextran-derived Schiff base (53, Fig. 5 ). This approach dramatically improved nystatin solubility in water [63] . Compound 53 completely inhibited the growth of C. albicans and C. neoformans at 20 lg/mL, while a concentration of 10 lg/mL was required for free nystatin to have a similar effect. Although the nystatin-dextran-derived Schiff base 53 was less active than nystatin itself, the former was shown to be much less toxic to normal cells [63] .
Antiviral activity
The use of vaccines may lead to the eradication of viral pathogens, such as smallpox, polio, and rubella. However, virus-re- 
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(13-15) Biological activities of Schiff baseslated and hepatitis C human immunodeficiency diseases have been the drawback of vaccine approaches [64] . Viral diseases are life-threatening for immunocompromised patients and a prompt treatment is required to overcome this problem.
Although there are many therapeutic options for viral infections, currently available antiviral agents are not yet fully effective, probably due to the high rate of virus mutation. They may also present any of a number of side effects. Salicylaldehyde Schiff bases of 1-amino-3-hydroxyguanidine tosylate are a good platform for the design of new antiviral agents [65, 66] . In fact, from a set of different 1-amino-3-hydroxyguanidine tosylate-derived Schiff bases, compound 54 ( Fig. 6 ) was shown to be very effective against mouse hepatitis virus (MHV), inhibiting its growth by 50% when employed at concentrations as low as 3.2 lM [66] .
Recently, Sriram and colleagues [66] reported the synthesis and antiviral activity of the abacavir-derived Schiff bases 55-65 (Fig. 6) . These compounds are a new series of abacavir prodrugs. Abacavir is a nucleoside analogue capable of inhibiting the activity of reverse transcriptase. It is used to treat human immunodeficiency virus (HIV) and AIDS, and is available under the trade name ZiagenÒ (GlaxoSmithKline). Compounds 55-65 were significantly effective against the human immunodeficiency virus-type 1 (HIV-1). The effective concentration (EC 50 ) of these abacavir-derived Schiff bases necessary to achieve 50% protection of human leukemic cells (CEM) against the cytopathic effect of HIV-1 was lower than 6 lM [66] . Notably, compound 57 was the most potent Schiff base, being effective at 50 nM. This compound is only toxic to CEM cells at concentrations higher than 100 lM, indicating its potential as a lead compound for the design of new anti-HIV-1 [66] .
Concluding remarks
Schiff bases have been widely explored for industrial applications. However, the biological activity of this class of compounds deserves further investigation. This becomes clear when plant pathogens are considered. Although the research on this subject is incipient, a number of reports disclosing the effects of the Schiff bases on the pathogens of clinical interest have recently been increasing. Schiff base compounds have been shown to be promising leads for the design of more efficient antimicrobial agents. Advances in this field will require analyses of the structure-activity relationships of the Schiff bases as well as the mechanism of action of these compounds. 
